Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults

This study was registered at www.ClinicalTrials.gov under reference identifier NCT02013687.